Brand
Biossance
Biossance was founded in 2016 as a consumer skincare arm of Amyris, a publicly traded biotechnology company that developed sugarcane-derived squalane through synthetic biology. The brand brings genuine biotech credentials to clean beauty — its squalane production technology was originally developed in partnership with the Gates Foundation for pharmaceutical applications. Biossance has been operating for nearly a decade with a growing body of clinical testing on its formulations.
In Catalog
9